Generic
Insulin Aspart
17 brands available in the market
At a glance
Insulin Aspart is a rapid-acting human insulin analog used to improve glycemic control in adults and children with diabetes mellitus.
Description
Insulin Aspart is a rapid-acting human insulin analog used to improve glycemic control in diabetes mellitus. It contains 30% soluble insulin aspart and 70% protamine-crystallized insulin aspart. It is homologous with regular human insulin except for a single substitution of proline by aspartic acid at position B28. It binds to insulin receptors on muscle and fat cells, facilitating glucose uptake and inhibiting glucose output from the liver.
Indications
- Improvement of glycemic control in adults and children with diabetes mellitus
Therapeutic class
Rapid Acting Insulin
Pharmacological class
Insulin Analog (Rapid-acting)
Pharmacology
The primary activity of Insulin Aspart is the regulation of glucose metabolism. It binds to insulin receptors on muscle and fat cells, facilitating cellular glucose uptake and simultaneously inhibiting glucose output from the liver. It is homologous with regular human insulin except for a single substitution of proline by aspartic acid at position B28, which ensures rapid absorption and faster onset of action.
Mechanism of action
Lowers blood glucose by binding to insulin receptors, facilitating glucose uptake in muscle and fat cells, and inhibiting glucose output from the liver.
Dosage
Adult Dose (Subcutaneous):
- Type 1 Diabetes: 0.2-0.6 units/kg/day in divided doses; maintenance: 0.5-1 unit/kg/day; nonobese: 0.4-0.6; obese: 0.6-1.2
- Type 2 Diabetes: Initial: 0.2-0.4 units/kg/day q8hr-q12hr; with intermediate (NPH) or long-acting insulin at bedtime
- 50-75% of insulin requirements provided by intermediate- or long-acting insulin; remainder as rapid-acting insulin before or at mealtimes
Child Dose (Type 1, >2 years): 0.5-1 unit/kg/day; adolescents <1.2 units/kg/day
Administration
Administer within 15 minutes before a meal or within 20 minutes after starting a meal as subcutaneous injection in upper arm, thigh, buttock or abdominal wall; abdominal wall injection results in faster absorption; rotate injection sites; do not administer IV or in insulin infusion pumps.
Missed dose
If you miss a dose, check your blood sugar and take the next dose accordingly; consult your doctor.
Side effects
Side Effects:
- Hypoglycemia
- Injection site reactions (redness, swelling, pain)
- Lipodystrophy
- Pruritus
- Rash
- Allergic reactions
Precautions & warnings
Precautions:
- Hypoglycemia is a common side effect; monitor blood sugar regularly
- Always carry sugary food or fruit juice for hypoglycemia symptoms (cold sweats, pale skin, tremors, weakness, anxiety)
- Rotate injection sites (to prevent lipodystrophy)
- Opened vials/cartridges stay good at room temperature for up to 4 weeks; unopened vials must be refrigerated (2°C-8°C)
- Do not use if preparation is no longer clear and colorless or contains particles
- Caution in renal and hepatic impairment (dose adjustment may be needed)
Contraindications
Contraindications:
- Hypoglycemia
- Hypersensitivity to Insulin Aspart or any of its excipients
Drug interactions
Drug Interactions:
- Oral antidiabetic agents, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAOIs, propoxyphene, salicylates, somatostatin analog, sulfonamide antibiotics increase effect
- Corticosteroids, niacin, danazol, diuretics, sympathomimetic agents, isoniazid, phenothiazine derivatives, somatropin, thyroid hormones, oral contraceptives, lithium decrease effect
- Beta-blockers, clonidine may mask symptoms of hypoglycemia
Food interactions
Food Interactions: It is unsafe to consume alcohol with Insulin Aspart.
Use in pregnancy
Use in Pregnancy: Category B; generally considered safe; animal studies show low or no adverse effects; limited human studies.
Pregnancy Category: B — always consult a doctor before taking during pregnancy.
Use in lactation
Use in Lactation: Safe during breastfeeding; does not pass into breastmilk in significant amount and is not harmful to baby.
Pediatric use
>2 years: 0.5-1 unit/kg/day; adolescents <1.2 units/kg/day.
Geriatric use
No specific data for elderly; however caution advised (limited experience in patients >75 years).
Renal / hepatic impairment
Renal Impairment: Dose adjustments may be needed (dosage may be reduced); frequent blood glucose monitoring recommended.
Hepatic Impairment: Dose adjustments may be needed (dosage may be reduced); frequent blood glucose monitoring recommended.
Overdose effects
Overdose: No specific overdose definition for insulin; hypoglycemia may develop; mild episodes treated with oral glucose or sugary products; severe episodes with glucagon (0.5-1 mg) IM/SC or IV glucose; oral carbohydrate recommended after regaining consciousness.
Storage conditions
Store at 2°C to 8°C in refrigerator; do not freeze; protect from light.
Chemical structure
Insulin Aspart